Current HLA Investigations on SARS-CoV-2 and Perspectives
- PMID: 34912378
- PMCID: PMC8667766
- DOI: 10.3389/fgene.2021.774922
Current HLA Investigations on SARS-CoV-2 and Perspectives
Abstract
The rapid, global spread of the SARS-CoV-2 virus during the current pandemic has triggered numerous efforts in clinical and research settings to better understand the host genetics' interactions and the severity of COVID-19. Due to the established major role played by MHC/HLA polymorphism in infectious disease course and susceptibility, immunologists and geneticists have teamed up to investigate its contribution to the SARS-CoV-2 infection and COVID-19 progression. A major goal of the Covid-19|HLA & Immunogenetics Consortium is to support and unify these efforts. Here, we present a review of HLA immunogenomics studies in the SARS-CoV-2 pandemic and reflect on the role of various HLA data, their limitation and future perspectives.
Keywords: COVID-19; HLA; MHC; SARS- CoV-2; association analysis; immunogenetics.
Copyright © 2021 Douillard, Castelli, Mack, Hollenbach, Gourraud, Vince and Limou.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Barquera R., Collen E., Di D., Buhler S., Teixeira J., Llamas B., et al. (2020). Binding Affinities of 438 <scp>HLA</scp> Proteins to Complete Proteomes of Seven Pandemic Viruses and Distributions of Strongest and Weakest <scp>HLA</scp> Peptide Binders in Populations Worldwide. HLA 96 (3), 277–298. 10.1111/tan.13956 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
